InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-56.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Worland Stephen T, 董事长兼首席执行官. Insider active across 1 company, notably eFFECTOR Therapeutics, Inc.. Aggregated, 8 disclosures have been recorded. Split: 1 buy · 0 sell. Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Worland Stephen T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
1,806 股@ €1.54555.0% 占其流量Common StockSEC:0000950170-24-061593:0
5,979 股@ €0.45714.9% 占其流量Common StockSEC:0001209191-23-055557:0
33,799 股@ €0.473528.9% 占其流量Common StockSEC:0001209191-23-045499:0
6,401 股@ €0.42214.9% 占其流量Common StockSEC:0001209191-23-029646:0
6,047 股@ €0.45395.0% 占其流量Common StockSEC:0001209191-22-057379:0
20,000 股@ €1.2805100.0% 占其流量Common StockSEC:0001209191-22-035277:0
标准退出：2022年9月5日 (T+90)
1,837 股@ €1.4749.6% 占其流量Common StockSEC:0001209191-22-029890:0
512,339 股Common StockSEC:0001209191-21-053686:0
8 条申报中的 8 条
About Worland Stephen T
WORLAND STEPHEN T is Président-Directeur Général and Chief Executive Officer at eFFECTOR Therapeutics, Inc. The record shows 8 filings, with activity captured in the recent filings tracked from 2021-08-27 to 2024-05-17, and the most frequent transaction nature is Attribution.
